Origin Agritech Announces Fiscal Year 2025 Results

Rhea-AI Summary

Origin Agritech (NASDAQ: SEED) reported fiscal 2025 results for the year ended September 30, 2025, including revenue of RMB 91.3 million (US$12.8M) and a net loss attributable to Origin of RMB 53.3 million (US$7.5M). The company cited Xinjiang factory upgrades as a primary driver of lower revenue.

Highlights include four new corn varieties, multiple regulatory approvals, expanded R&D platforms and germplasm resources, a restored Xinjiang processing line, cash of RMB 15.9 million, and increased financing inflows in fiscal 2025.

Positive

• Cash balance increased to RMB 15.9 million as of September 30, 2025
• Net cash provided by financing of RMB 44.3 million in fiscal 2025
• Launched four new corn varieties and secured multiple provincial and national approvals
• R&D expansion: four provincial/ministerial platforms and >200,000 germplasm resources

Negative

• Revenue declined by ~19.5% to RMB 91.3 million in fiscal 2025
• Net loss attributable to Origin of RMB 53.3 million versus prior-year net income
• Operating expenses rose to RMB 64.2 million, up from RMB 52.7 million year-over-year

Key Figures

FY2025 Revenue: RMB 91.3M (US$12.8M) FY2024 Revenue: RMB 113.4M (US$16.2M) Net loss (cont. ops): RMB 58.0M (US$8.2M) +5 more

8 metrics

FY2025 Revenue RMB 91.3M (US$12.8M) Fiscal year ended September 30, 2025; down from FY2024

FY2024 Revenue RMB 113.4M (US$16.2M) Prior fiscal year ended September 30, 2024

Net loss (cont. ops) RMB 58.0M (US$8.2M) FY2025 from continuing operations; versus prior-year income

Net income FY2024 RMB 20.7M (US$3.0M) Net income attributable to Origin in FY2024

Cash & equivalents RMB 15.9M (US$2.2M) Balance as of September 30, 2025; up from RMB 8.4M

Total borrowings RMB 8.0M (US$1.1M) As of September 30, 2025; up from RMB 4.95M

Net cash used in ops RMB 22.9M (US$3.2M) FY2025, versus RMB 15.0M (US$2.1M) in FY2024

Shelf registration size $30,000,000 Registered under Form F-3 shelf for ordinary shares, warrants, units

Market Reality Check

Price: $1.30 Vol: Volume 137,574 is 7x the ...

high vol

$1.30 Last Close

Volume Volume 137,574 is 7x the 20-day average of 19,657, signaling elevated pre-news positioning. high

Technical Trading below the 200-day MA at 1.24, despite sitting well under the 52-week high of 2.70.

Peers on Argus

SEED was down 2.36% while the momentum scanner only flagged BIOX moving up 5.04%...

1 Up

SEED was down 2.36% while the momentum scanner only flagged BIOX moving up 5.04%. Broader peers show mixed moves (e.g., NITO up 4.13%, ENFY down 6.67%), pointing to a stock-specific reaction to earnings rather than a coordinated sector trade.

Previous Earnings Reports

3 past events · Latest: Jun 26 (Negative)

Same Type Pattern 3 events

Date	Event	Sentiment	Move	Catalyst
Jun 26	Interim 2025 results	Negative	-16.8%	H1 2025 revenue and profit deteriorated to a net loss with weaker cash.
Feb 10	FY2024 results	Positive	-8.4%	FY2024 delivered 24.6% revenue growth and solid profitability with R&D wins.
May 15	H1 2024 results	Positive	-4.4%	Strong H1 2024 growth, margin improvement, and progress in GMO corn approvals.

Pattern Detected

Earnings releases often saw negative price reactions, including selloffs even on strong financial reports.

Recent Company History

Across the last three earnings events, Origin Agritech shifted from strong FY2024 profitability to weakening performance in 2025. The FY2024 report highlighted revenue of RMB 113.4M and net income of RMB 20.7M. By the half year ended Mar 31, 2025, revenue had declined to $10.1M with a net loss of $3.6M and a cash balance of only $0.33M. Those updates consistently triggered negative price reactions, framing today’s full-year FY2025 loss and higher spending within a continuing deterioration from the prior uptrend.

Historical Comparison

earnings

+9.9 %

Average Historical Move

Historical Analysis

In the past year, SEED’s three earnings updates moved an average of ±9.87%, often skewing negative even on strong results, underscoring a pattern of cautious market reception to financial disclosures.

Typical Pattern

Earnings have transitioned from strong FY2024 growth and profit to H1 2025 revenue declines, rising losses, and tighter liquidity, with the latest FY2025 update extending this trend alongside heavier investment in R&D and infrastructure.

Regulatory & Risk Context

Active S-3 Shelf · $30,000,000

Shelf Active

Active S-3 Shelf Registration 2025-10-15

$30,000,000 registered capacity

An effective Form F-3 shelf filed on 2025-10-15 registers up to $30,000,000 of ordinary shares, warrants, and units for issuance over three years. As of the latest data, usage count is 0, indicating full capacity remains available for potential future capital raises.

Market Pulse Summary

This announcement details FY2025 results marked by revenue of RMB 91.3M, a swing to a RMB 58.0M net ...

Analysis

This announcement details FY2025 results marked by revenue of RMB 91.3M, a swing to a RMB 58.0M net loss, and higher operating and R&D spending as Origin scales its Xinjiang facility and gene-editing platform. Cash rose to RMB 15.9M but borrowings increased to RMB 8.0M. An effective $30,000,000 Form F-3 shelf provides flexibility for future financing. Investors may watch subsequent earnings, cash flows, and utilization of this shelf to gauge execution on the multi-stage recovery plan.

Key Terms

form 20-f, gene editing, gmos

3 terms

form 20-f regulatory

"The Company has filed its annual report on Form 20-F for the fiscal year"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

gene editing medical

"authorization for multiple gene editing traits, including leaf angle, plant height"

Gene editing is a set of laboratory techniques that change the DNA inside living cells to add, remove, or alter specific genes, like using precise 'cut-and-paste' tools to edit an instruction manual for a living organism. It matters to investors because successful edits can produce new therapies, improve agricultural products, or create commercial advantages; progress, safety, regulatory approvals, and patent control all affect a company’s value and risk profile.

gmos medical

"commercialization of GMOs and gene editing through our strategic alliance"

GMOs are plants, animals or microbes whose genetic material has been intentionally changed in a lab to add, remove or alter specific traits—think of it like updating a recipe so the result behaves differently. For investors, GMOs matter because they affect product yields, production costs, regulatory approvals, patent rights and consumer acceptance; those factors can change a company’s sales, risks and long‑term competitive position in food, biotech and agricultural markets.

AI-generated analysis. Not financial advice.

Announces Filing of Annual Report on Form 20-F for Fiscal Year 2025

BEIJING, Jan. 30, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced financial results for the year ended September 30, 2025.

Business Accomplishments and Highlights for the Year Ended September 30, 2025:

Partnerships & Industry Engagement:

• In January 2025, Origin announced a three-way partnership with China Agricultural University (the world's top-ranked institution in agricultural science) and the Beijing Academy of Agricultural and Forestry Sciences, establishing a comprehensive R&D initiative focused on corn "smart plant type" improvement and innovative variety development
• The Company signed cooperation agreements with 12 prominent agricultural companies at the Sanya International Seed Industry Scientist Conference
• Origin launched the "Golden Harvest Club," a strategic alliance aimed at strengthening relationships within its distribution ecosystem

Product Portfolio & Regulatory Approvals:

• The Company launched four new corn varieties at its August 2025 Industry Summit: Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728
• Jinqiao 8 received approval for introduction in five provinces (Anhui, Jiangsu, Shandong, Henan, and Hubei)
• Jingke 317 and Aoyu 728 received National Trial approval
• Xundan 203 received approval in Henan Province

Distribution Network Expansion:

• In August 2025, Origin hosted its Achievements Exhibition and Seed Industry Innovation Summit in Zhengzhou, attracting over 700 distributor partners from across China and more than 30 industry experts
• Distributors actively participated in the new product launch and ordering process, demonstrating strong market interest in Origin's product pipeline

Production & Processing Capabilities:

• On August 21, 2025, Origin's Xinjiang production facility commenced full-scale seed processing operations for the 2025 season
• The facility operates a fully automated processing line integrating cleaning, drying, threshing, precision sorting, coating, and packaging operations
• Advanced seed coating technology and real-time monitoring systems ensure optimal seed quality and viability

Research & Development Infrastructure:

• The Company established four provincial and ministerial R&D platforms with research bases in Beijing, Hainan, and Henan
• Origin accumulated over 200,000 corn germplasm resources
• The Company received authorization for multiple gene editing traits, including leaf angle, plant height, and rust resistance

Fiscal Year 2025 Financial Results:

For the fiscal year ended September 30, 2025, revenue was RMB 91.3 million (US$12.8 million), compared to RMB 113.4 million (US$16.2 million) for the fiscal year ended September 30, 2024. The decrease in revenues was primarily attributed to equipment upgrades and modernization at the Xinjiang factory, which led to a reduction and halt in external seed production services, as well as a decrease in sales of non-proprietary varieties.

Total operating expenses for the fiscal year ended September 30, 2025, were RMB 64.2 million (US$9.0 million), compared to operating expenses of RMB 52.7 million (US$7.5 million) in fiscal year 2024.

• Selling and marketing expenses for fiscal year 2025 were RMB 7.0 million (US$1.0 million), compared to RMB 6.3 million (US$0.9 million) in fiscal year 2024.
• General and administrative expenses for the fiscal year ended September 30, 2025, were RMB 40.2 million (US$5.7 million), compared to RMB 36.0 million (US$5.1 million) year-over-year.
• Research and development expenses were RMB 13.0 million (US$1.8 million) in fiscal year 2025, compared to RMB 10.1 million (US$1.4 million) in fiscal year 2024.

Net loss from continuing operations for the fiscal year ended September 30, 2025, was RMB 58.0 million (US$8.2 million), compared with net income from continuing operations of RMB 18.7 million (US$2.7 million) in fiscal year 2024.

Net loss attributable to Origin for the fiscal year ended September 30, 2025 was RMB 53.3 million (US$7.5 million), compared to the net income of RMB 20.7 million (US$3.0 million) for the fiscal year ended September 30, 2024.

Liquidity

As of September 30, 2025, we had approximately RMB 15.9 million (US$2.2 million) in cash and cash equivalents, compared to RMB 8.4 million (US$1.2 million) as of September 30, 2024. Total borrowings as of September 30, 2025, were RMB 8.0 million (US$1.1 million), compared to RMB 4.95 million (US$0.7 million) as of September 30, 2024.

Net cash used in operating activities was RMB 22.9 million (US$3.2 million) during fiscal year 2025, compared with net cash used in operating activities of RMB 15.0 million (US$2.1 million) for the fiscal year ended September 30, 2024.

Net cash used in investing activities was RMB 13.7 million (US$1.9 million) for the fiscal year ended September 30, 2025, compared with net cash used in investing activities of RMB 5.0 million (US$0.7 million) for the fiscal year ended September 30, 2024.

Net cash provided by financing activities was RMB 44.3 million (US$6.2 million) for the fiscal year ended September 30, 2025, compared with net cash provided by financing activities of RMB 4.5 million (US$0.6 million) for the fiscal year ended September 30, 2024.

Management Commentary

Mr. Weibin Yan, CEO of Origin Agritech, commented, "Fiscal year 2025 has been a year of recovery for Origin Agritech. We have fully restored our team, research capabilities, seed production and processing facilities, and sales network infrastructure, and we are now ready to march forward under our renewed leadership. In November 2024, we announced our three-stage strategic plan: Recovery in 2025 and 2026, Stand-Up from 2027 to 2029, and a return to an industry-leading position from 2030 to 2032. In 2025, we fully put our senior leadership in place, expanded our sales team from 63 to 106, upgraded our Beijing and Sanya research stations, opened a new station in Zhengzhou, and began construction on our Guiyang facility, scheduled to open in Q1 2026. Our research pipeline is now stocked with the most competitive germplasms, in-house-developed AI supports our breeding programs, and we are accelerating the commercialization of GMOs and gene editing through our strategic alliance with China Golden-mark Biotech. With our Xinjiang facility restored to industry-leading standards, a new sales force in Northeast China, and Beijing Origin obtaining its seed production and operation license in December 2025, we are confident that Origin Agritech is positioned to deliver significant value to our shareholders in the years ahead."

Annual Report Now Available

The Company has filed its annual report on Form 20-F for the fiscal year ended September 30, 2025, with the Securities and Exchange Commission ("SEC"). The annual report on Form 20-F can be accessed on the SEC's website at http://www.sec.gov and the Company's investor relations website at https://originagritech.com/investor-relations/.

CONFERENCE CALL & AUDIO WEBCAST

Origin will host a conference call on Monday, February 2, at 8 a.m. ET with the investment community to discuss the Company's financial results and provide a business update. The conference call will be led by Mr. Weibin Yan, Chief Executive Officer, and Mr. Patrick Cheng, Chief Financial Officer.

To access the call by phone, please call 1-800-245-3047 (United States) or 1-203-518-9765 (International) using the conference ID: ORIGIN.

To avoid delays, we encourage participants to dial into the conference call 15 minutes before the scheduled start time. The webcast can be accessed at the following link: https://viavid.webcasts.com/starthere.jsp?ei=1750839&tp_key=695fe18547.

About Origin Agritech Limited

Origin Agritech Limited, founded in 1997 and headquartered in Origin R&D Center, Songzhuang, Tongzhou in Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnologies, Origin Agritech's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and pest resistance (Bt) traits. For further information, please visit the Company's website at www.originagritech.com. The Company also maintains an X account for updating investors on Company and industry developments which is https://x.com/origin_agritech.

For more information, please contact:
Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: bing.lang@originseed.com.cn

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com

View original content:https://www.prnewswire.com/news-releases/origin-agritech-announces-fiscal-year-2025-results-302675279.html

SOURCE Origin Agritech Limited

FAQ

What were Origin Agritech's revenue and net result for fiscal year 2025 (SEED)?

Revenue for fiscal 2025 was RMB 91.3 million (US$12.8M), and net loss attributable to Origin was RMB 53.3 million. According to the company, Xinjiang factory upgrades and reduced external seed services drove the year-over-year revenue decline.

Why did Origin Agritech (SEED) report lower revenue in fiscal 2025?

Lower revenue was primarily due to equipment upgrades that reduced external seed production services. According to the company, modernization at the Xinjiang facility and decreased non-proprietary variety sales materially reduced 2025 revenue.

How strong is Origin Agritech's cash position after fiscal 2025 (SEED)?

Origin held RMB 15.9 million in cash and equivalents as of September 30, 2025. According to the company, cash rose from RMB 8.4 million in the prior year, supported by RMB 44.3 million net cash from financing activities.

What operational progress did Origin Agritech announce for 2025 (SEED)?

Origin restored Xinjiang seed processing to full-scale operations and opened new R&D bases. According to the company, the year included a resumed Xinjiang processing line, four provincial R&D platforms, and expanded sales headcount from 63 to 106.

Did Origin Agritech (SEED) make product or regulatory advances in fiscal 2025?

Yes — Origin launched four new corn varieties and received provincial and national trial approvals for several varieties. According to the company, Jinqiao 8 was approved in five provinces and national trial approvals were granted for Jingke 317 and Aoyu 728.

What liquidity and cash flow trends should investors note for Origin Agritech (SEED)?

Operating cash use increased to RMB 22.9 million while investing cash use rose to RMB 13.7 million in 2025. According to the company, these outflows were offset by substantial financing inflows of RMB 44.3 million during the year.